Atypical epithelial proliferation in fallopian tubes in prophylactic salpingo-oophorectomy specimens from BRCA1 and BRCA2 germline mutation carriers

被引:105
|
作者
Carcangiu, ML
Radice, P
Manoukian, S
Spatti, G
Gobbo, M
Pensotti, V
Crucianelli, R
Pasini, B
机构
[1] Ist Nazl Tumori, Dept Pathol, I-20133 Milan, Italy
[2] Ist Nazl Tumori, Dept Expt Oncol, I-20133 Milan, Italy
[3] Ist Nazl Tumori, Dept Prevent & Predict Med, I-20133 Milan, Italy
[4] Ist Nazl Tumori, Gynecol Unit, I-20133 Milan, Italy
[5] FIRC, Inst Mol Oncol, Milan, Italy
关键词
BRCA1; prophylactic salpingo-oophorectomy; fallopian tube; atypical hyperplasia; carcinoma in situ;
D O I
10.1097/01.pgp.0000101082.35393.84
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Although growing numbers of tubal carcinomas in carriers of BRCA1 and BRCA2 germline mutations have been reported, very little is known about the nature and frequency of their possible precursor lesions. The aim of this study is to investigate the occurrence of atypical proliferative tubal lesions in grossly normal fallopian tubes from 26 women with BRCA1 and BRCA2 germline mutations who underwent prophylactic salpingo-ooophorectomy and whose ovaries were histologically negative for carcinoma. Fallopian tubes from 49 women who had undergone hysterectomy with salpingo-oophorectomy for uterine leiomyoma served as controls. In the 22 BRCA1-mutated women, there were two in situ carcinomas and two atypical hyperplasias of the tubal epithelium. The tubes of the BRCA2-mutated women and of the 49 control women did not show any atypical proliferation. The frequency of proliferative lesions of the tubal epithelium, including in situ carcinoma, appears to be increased in BRCA1 mutation carriers. Removal and thorough examination of the fallopian tubes at the time of surgical prophylaxis for ovarian cancer is therefore recommended.
引用
收藏
页码:35 / 40
页数:6
相关论文
共 50 条
  • [21] Risk-reducing salpingo-oophorectomy in patients with germline mutations in BRCA1 or BRCA2
    Kauff, Noah D.
    Barakat, Richard R.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (20) : 2921 - 2927
  • [22] Prophylactic Mastectomy and Risk-Reducing Salpingo-oophorectomy in BRCA1/2 Mutation Carriers
    Kara N. Maxwell
    Susan M. Domchek
    Current Breast Cancer Reports, 2012, 4 (3) : 199 - 206
  • [23] Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers:: a prospective cohort study
    Domchek, SM
    Friebel, TM
    Neuhausen, SL
    Wagner, T
    Evans, G
    Isaacs, C
    Garber, JE
    Daly, M
    Eeles, R
    Matloff, E
    Tomlinson, GE
    Van't Veer, L
    Lynch, HT
    Olopade, O
    Weber, BL
    Rebbeck, TR
    LANCET ONCOLOGY, 2006, 7 (03): : 223 - 229
  • [24] Comparing Coordinated Versus Sequential Salpingo-Oophorectomy for BRCA1 and BRCA2 Mutation Carriers With Breast Cancer
    Chapman, Jocelyn S.
    Roddy, Erika
    Panighetti, Anna
    Hwang, Shelley
    Crawford, Beth
    Powell, Bethan
    Chen, Lee-may
    CLINICAL BREAST CANCER, 2016, 16 (06) : 494 - 499
  • [25] Prophylactic Mastectomy and Risk-Reducing Salpingo-oophorectomy in BRCA1/2 Mutation Carriers
    Maxwell, Kara N.
    Domchek, Susan M.
    CURRENT BREAST CANCER REPORTS, 2012, 4 (03) : 199 - 206
  • [26] Breast cancer screening in BRCA1 and BRCA2 mutation carriers after risk reducing salpingo-oophorectomy
    Fakkert, Ingrid E.
    Jansen, Liesbeth
    Meijer, Kees
    Kok, Theo
    Oosterwijk, Jan C.
    Mourits, Marian J. E.
    de Bock, Geertruida H.
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 129 (01) : 157 - 164
  • [27] Dysplastic changes of the fallopian tubes in BRCA-1 and BRCA-2 germline mutation carriers at prophylactic oophorectomy
    Carcangiu, ML
    Radice, P
    Spatti, G
    Pasini, B
    MODERN PATHOLOGY, 2002, 15 (01) : 193A - 193A
  • [28] Dysplastic changes of the fallopian tubes in BRCA-1 and BRCA-2 germline mutation carriers at prophylactic oophorectomy
    Carcangiu, ML
    Radice, P
    Spatti, G
    Pasini, B
    LABORATORY INVESTIGATION, 2002, 82 (01) : 193A - 193A
  • [29] Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.
    Kauff, ND
    Satagopan, JM
    Robson, ME
    Scheuer, L
    Hensley, M
    Hudis, CA
    Ellis, NA
    Boyd, J
    Borgen, PI
    Barakat, RR
    Norton, L
    Offit, K
    NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (21): : 1609 - 1615
  • [30] Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations
    Rebbeck, TR
    Lynch, HT
    Neuhausen, SL
    Narod, SA
    van't Veer, L
    Garber, JE
    Evans, G
    Isaacs, C
    Daly, MB
    Matloff, E
    Olopade, OI
    Weber, BL
    NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (21): : 1616 - 1622